title: Multivariate risk assessment and risk score cards in hypertension.
abstract: Cardiovascular disease represents the leading cause of morbidity and mortality in Western countries, and hypertension-related cardiovascular events affect about 37 million people per year, worldwide. In this perspective, hypertensive patients are at increased risk to experience cardiovascular events during life-long period, and treatment of high blood pressure represents one of the most effective strategies to reduce global cardiovascular risk. However, due to its multifactorial pathophysiology and its frequent association with other relevant risk factors and clinical conditions, treatment of hypertension requires an integrated approach, including life-style measures, antihypertensive drugs and other therapies. Yet, worldwide general practitioners continue to focus their attention on the management of a single risk factor, eg, blood pressure, rather than to global cardiovascular risk profile. In this view, modem strategies of cardiovascular prevention in hypertensive patients should move from a single risk factor based approach toward a more comprehensive risk evaluation in the individual patient. In other words, it is important to define the global cardiovascular risk to manage hypertensive patients at high-risk, rather than to focus on the high level of a single risk factor, for reducing cardiovascular morbidity and mortality in the general population, as well as in hypertensive population.
authors: Cardiology, II Faculty of Medicine, University of Rome La Sapienza, Sant'Andrea Hospital, Rome, Italy.
authors: Giuliano
authors: G
authors: Tocci
authors: Valentina
authors: V
authors: Valenti
authors: Sebastiamo
authors: S
authors: Sciarretta
authors: Massimo
authors: M
authors: Volpe-
mesh_terms: D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control; D002784:Cholesterol / Q000097:blood; D015438:Health Behavior; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D017202:Myocardial Ischemia / Q000453:epidemiology / Q000517:prevention & control*; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors
chemical_list: D002784:Cholesterol
references: Lancet. 1997 Feb 15;349(9050):454-7
references: 9040574
references: Lancet. 1998 Jun 13;351(9118):1755-62
references: 9635947
references: N Engl J Med. 2005 Apr 7;352(14):1425-35
references: 15755765
references: Diabetes Care. 2004 Jan;27 Suppl 1:S65-7
references: 14693929
references: Lancet. 2002 Mar 23;359(9311):995-1003
references: 11937178
references: Lancet. 2002 Dec 14;360(9349):1903-13
references: 12493255
references: J Hum Hypertens. 2005 May;19(5):331-9
references: 15744333
references: JAMA. 2003 May 21;289(19):2560-72
references: 12748199
references: Lancet. 2003 Apr 5;361(9364):1149-58
references: 12686036
references: J Hypertens. 2003 Jun;21(6):1011-53
references: 12777938
references: Am J Hypertens. 2004 Nov;17(11 Pt 1):1068-74
references: 15533736
references: Lancet. 2004 Sep 11-17;364(9438):937-52
references: 15364185
references: N Engl J Med. 2000 Jan 6;342(1):1-8
references: 10620642
references: Lancet. 2001 Sep 29;358(9287):1033-41
references: 11589932
references: BMJ. 1998 Sep 12;317(7160):703-13
references: 9732337
references: J Am Coll Cardiol. 1999 Oct;34(4):1348-59
references: 10520820
references: Circulation. 2002 Dec 17;106(25):3143-421
references: 12485966
references: Am Heart J. 1991 Jan;121(1 Pt 2):293-8
references: 1985385
references: Am J Hypertens. 2000 Jan;13(1 Pt 2):3S-10S
references: 10678282
references: JAMA. 2003 May 14;289(18):2363-9
references: 12746359
references: JAMA. 1986 Nov 28;256(20):2823-8
references: 3773199
references: BMJ. 1998 Jul 18;317(7152):167-71
references: 9665894
references: Heart. 1999 Jan;81(1):40-6
references: 10220543
references: J Am Coll Cardiol. 2005 Oct 4;46(7):1225-8
references: 16198835
references: Int J Epidemiol. 2002 Aug;31(4):817-22
references: 12177028
references: J Hypertens. 2003 Nov;21(11):1983-92
references: 14597836
references: Eur Heart J. 2000 Mar;21(5):365-70
references: 10666350
references: N Engl J Med. 2003 Jan 30;348(5):383-93
references: 12556541
references: JAMA. 2002 Dec 18;288(23):2981-97
references: 12479763
references: Lancet. 2000 Dec 9;356(9246):1955-64
references: 11130523
references: Lancet. 1990 Mar 31;335(8692):765-74
references: 1969518
references: Lancet. 2004 Jun 19;363(9426):2022-31
references: 15207952
references: Lancet. 2005 Sep 10-16;366(9489):895-906
references: 16154016
references: Eur Heart J. 2003 Jun;24(11):987-1003
references: 12788299
references: JAMA. 1979 Dec 7;242(23):2562-71
references: 490882
references: N Engl J Med. 2000 Jan 20;342(3):145-53
references: 10639539
references: Blood Press. 2005;14(4):196-209
references: 16126553
references: Lancet. 1990 Apr 7;335(8693):827-38
references: 1969567
references: N Engl J Med. 2001 Nov 1;345(18):1291-7
references: 11794147
references: Circulation. 1998 May 12;97(18):1876-87
references: 9603549
references: Am J Hypertens. 2002 Oct;15(10 Pt 1):917-23
references: 12372681
references: N Engl J Med. 2004 Apr 8;350(15):1495-504
references: 15007110